Vivek Ramaswamy Quotes

There's always going to be the need for new medications, better medications.

In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.

I keep encouraging the pharmaceutical companies to put more money into R&D.

We have 28,000 drug patents held by American universities that are not being developed.

Fifty million Americans have dementia and other brain illnesses. To gather together the minds that exist and see how we can tackle these ailments together, that is the work that is in front of us: to have a map of the human brain, an understanding of the roadways, and an understanding of the traffic on the roadways.

In my opinion, in addition to the success we have achieved in launching new Vants and in pursuing development of a variety of drugs, one of our most important achievements has been the growth of Roivant itself as a platform to support the efficient identification and advancement of medicines across all of the companies in the Roivant family.

It seems paradoxical that, as medical scientists make huge advances in discovering the mechanisms of common diseases, fewer and fewer innovative drugs are reaching the market.

There is no doubt that the Mindset failure is a major setback for Axovant, but it is not the end of the road.

I was criticized for saying that Pfizer doesn't know how to make a molecule right.

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price hikes that these drugs offer enough revenue to offset the rising generic entry costs, and start to entice competition.

The discovery of artemisinin was an example of successful collective efforts.

I had seen a Pfizer's pilot plant in 1965 and decided that, 'I'll build a Pfizer.' If not Pfizer, I have built Dr Reddy's, which is no less respectable.

I can't comment on the internal decision-making at other companies, but RVT-101 has the potential to be a very valuable product in the treatment of Alzheimer's, which is a huge unmet medical need.

My name is Matthew Walker, I am a professor of neuroscience and psychology at the University of California, Berkeley, and I am the author of the book 'Why We Sleep.'

The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with bureaucratic institutions within which they often sit.

While I am prepared to look at all options and to think 'outside the box' for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public.

I run a number of different brain banks.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

Why is there no cure for cancer? Because the medical industry doesn't want one! And the pharmaceutical industry doesn't want one! Because they would lose too much money!

One has to understand the functioning of the normal brain before studying the badly malfunctioning brain.

To start with, pharma was an industry based on innovation, drug discovery.

My choice of learning pharmacy was driven by my interests, curiosity, and a desire to seek new medicines for patients.

Think of all the nonsense you had to learn in psychology courses. None of which was testable. None of which was measurable. We had behaviorism, Freudian psychology, all of these theories that you learn in psychology. Totally untestable. Now, we can test it, because physics allows us to calculate energy flows in the brain.

High Price: A Neuroscientist's Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society.